SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aspira Pathlab & Diagnostics informs about scrutinizer's report

12 Sep 2022 Evaluate
Aspira Pathlab & Diagnostics has informed that the 49th Annual General Meeting of Aspira Pathlab & Diagnostics held on Saturday, September 10, 2022 at 11:30 AM through Video Conference in compliance with the provisions of Companies Act, 2013 & circulars issued by Ministry of Corporate Affairs in this behalf. In this regard, the Company has enclosed the following: Scrutinizer's Report dated September 12, 2022 pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4) (xii) of the Companies (Management and Administration) Rules, 2014; Voting results of remote e-voting and e-voting during AGM, pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

59.35 1.15 (1.98%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×